Show simple item record

dc.contributor.authorÖZGÜLER, YEŞİM
dc.contributor.authorHATEMİ, GÜLEN
dc.contributor.authorESATOĞLU, SİNEM NİHAL
dc.date.accessioned2023-10-10T12:10:13Z
dc.date.available2023-10-10T12:10:13Z
dc.date.issued2023
dc.identifier.citationÖZGÜLER Y., ESATOĞLU S. N., HATEMİ G., "Current pharmacological solutions for Behcet's syndrome", EXPERT OPINION ON PHARMACOTHERAPY, cilt.24, sa.2, ss.221-231, 2023
dc.identifier.issn1465-6566
dc.identifier.otherav_1b52ebc2-de22-4025-b831-d23a38d5f273
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/189938
dc.identifier.urihttps://doi.org/10.1080/14656566.2022.2155047
dc.description.abstractIntroductionBehcet's syndrome (BS) has a heterogeneous clinical phenotype, and its clinical manifestations may respond differently to drugs commonly used to treat BS. The type, dose, and duration of immunomodulatory, immunosuppressive, and biologic agents should be tailored individually.Areas coveredWe reviewed the literature for articles on BS management that were published until June 2022 and summarized the management options in BS for each type of organ involvement. We aimed to cover all currently available pharmacological agents used in BS, as well as surgical and interventional options, focusing on recent evidence.Expert opinionThe management aims in BS are to preserve function and quality of life and to avoid damage. The choice of treatment modalities depends on the organs that are actively involved, the severity of that involvement, and prognostic factors. A treat-to-attack strategy would help improve long-term outcomes in BS.
dc.language.isoeng
dc.subjectFarmakoloji
dc.subjectFarmakoloji, Toksikoloji ve Eczacılık (çeşitli)
dc.subjectGenel Farmakoloji, Toksikoloji ve Eczacılık
dc.subjectFarmakoloji (tıbbi)
dc.subjectİlaç Rehberleri
dc.subjectSağlık Bilimleri
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri
dc.subjectTemel Eczacılık Bilimleri
dc.subjectEczacılık
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleCurrent pharmacological solutions for Behcet's syndrome
dc.typeMakale
dc.relation.journalEXPERT OPINION ON PHARMACOTHERAPY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume24
dc.identifier.issue2
dc.identifier.startpage221
dc.identifier.endpage231
dc.contributor.firstauthorID4309646


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record